Literature DB >> 32040961

Acute Statin Administration Reduces Levels of Steroid Hormone Precursors.

Edra London1, Christina Tatsi1, Steven J Soldin2, Christopher A Wassif1, Peter Backlund3, David Ng4, Leslie G Biesecker4, Constantine A Stratakis1.   

Abstract

Cholesterol-lowering statin drugs are used by approximately 25% of US adults 45 years of age and older and frequency of use is even higher among the elderly. Cholesterol provides the substrate for steroid hormone synthesis and its intracellular concentrations are tightly regulated. Our aim was to evaluate whether statin use acutely changes the circulating levels of cortisol, other glucocorticoid precursor molecules and their metabolites. Fourteen subjects not taking statins were administered a single oral dose (2 mg) of pitavastatin. Blood samples collected at baseline and 24 h post-treatment were analyzed for plasma cholesterol and steroid hormone profile. A parallel study in mice entailed the administration of atorvastatin (10 mg/kg) via orogastric delivery for three consecutive days. Cholesterol and corticosterone levels were quantified at baseline and at 1-day and 1-week post-treatment. Several precursor molecules in the steroidogenic pathway (corticosterone, cortisone, and 11-deoxycortisol) were significantly decreased 24 h after administration of a single dose of pitavastatin in human study subjects. Their circulating cholesterol concentrations were unchanged. In mice, there were no significant differences in serum cholesterol or corticosterone at 1-day or 1-week post-treatment compared to both pre-treatment baseline levels and control group levels. We conclude that acute dysregulation of the production of certain glucocorticoid precursor molecules was observed after a single treatment with a lipophilic statin drug. This may be of clinical relevance for individuals with underlying or subclinical adrenal insufficiency. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32040961      PMCID: PMC7495505          DOI: 10.1055/a-1099-9556

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  39 in total

Review 1.  Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Amirhossein Sahebkar; Jana Rathouska; Luis E Simental-Mendía; Petr Nachtigal
Journal:  Pharmacol Res       Date:  2015-11-04       Impact factor: 7.658

2.  Metabolic Syndrome as a Predictor of Adrenal Functional Status: A Discriminant Multivariate Analysis Versus Logistic Regression Analysis.

Authors:  Charalampos Tsentidis; Andreas Bampilis; Vasiliki Ntova; Dimitrios Fragkos; Christos Panos; Christina Limniati; Georgia Kassi
Journal:  Horm Metab Res       Date:  2018-11-07       Impact factor: 2.936

3.  Plasma cortisol and testosterone in hypercholesterolaemia treated with clofibrate and lovastatin.

Authors:  G Mastroberardino; C Costa; M S Gavelli; E Vitaliano; F Rossi; A Catalano; R Barletta; G Guarini
Journal:  J Int Med Res       Date:  1989 Jul-Aug       Impact factor: 1.671

4.  Lipid Profiles in Lyme Borreliosis: A Potential Role for Apheresis?

Authors:  Richard Straube; Karin Voit-Bak; A Gor; Til Steinmeier; George P Chrousos; Bernhard Otto Boehm; Andreas L Birkenfeld; Mahmoud Barbir; Wladimir Balanzew; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2019-05-09       Impact factor: 2.936

Review 5.  Early steps in steroidogenesis: intracellular cholesterol trafficking.

Authors:  Walter L Miller; Himangshu S Bose
Journal:  J Lipid Res       Date:  2011-10-05       Impact factor: 5.922

6.  Effects of inhibition of cholesterol synthesis by simvastatin on the production of adrenocortical steroid hormones and ACTH.

Authors:  M J Mol; A F Stalenhoef; P M Stuyt; A R Hermus; P N Demacker; A Van 'T Laar
Journal:  Clin Endocrinol (Oxf)       Date:  1989-12       Impact factor: 3.478

7.  Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.

Authors:  Edra London; Christopher A Wassif; Anelia Horvath; Christina Tatsi; Anna Angelousi; Alexander S Karageorgiadis; Forbes D Porter; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-07-23       Impact factor: 5.958

8.  A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study).

Authors:  M Kanat; E Serin; A Tunckale; O Yildiz; S Sahin; M Bolayirli; H Arinc; A Dirican; Y Karagoz; Y Altuntas; H Celebi; A Oguz
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

9.  Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE).

Authors:  C Noel Bairey Merz; Marian B Olson; B Delia Johnson; Vera Bittner; T Keta Hodgson; Sarah L Berga; Glenn D Braunstein; Carl J Pepine; Steven E Reis; George Sopko; Sheryl F Kelsey
Journal:  Am J Med       Date:  2002-12-15       Impact factor: 4.965

10.  Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts.

Authors:  R I Kelley
Journal:  Clin Chim Acta       Date:  1995-04-30       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.